Whitefort Capital Management, LP - 20 Feb 2025 SCHEDULE 13D/A Report for Arbutus Biopharma Corp Common Shares, without par value (ABUS)

Filing Manager
Whitefort Capital Management, LP
Reporting Manager
Whitefort Capital Master Fund, LP
Security
Arbutus Biopharma Corp Common Shares, without par value
Symbol
ABUS
Shares outstanding
190M shares
Disclosed Ownership
13.3M shares
Ownership
7%
Form type
SCHEDULE 13D/A
Filing time
21 Feb 2025, 09:00:14 UTC
Date of event
20 Feb 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Whitefort Capital Master Fund, LP 7% 13.3M 0 13.3M /s/ David Salanic David Salanic, Co-Managing Member of Whitefort Capital GP, LLC, its General Partner 0001704387
Whitefort Capital GP, LLC 7% 13.3M 0 13.3M /s/ David Salanic David Salanic, Co-Managing Member
Whitefort Capital Management, LP 7% 13.3M 0 13.3M /s/ David Salanic David Salanic, Co-Managing Partner 0001884931
Whitefort Capital Management GP, LLC 7% 13.3M 0 13.3M /s/ David Salanic David Salanic, Co-Managing Member
David Salanic 7% 13.3M 0 13.3M /s/ David Salanic David Salanic
Joseph Kaplan 7% 13.3M 0 13.3M /s/ Joseph Kaplan Joseph Kaplan